Lifeboat Foundation

Researchers from The University of Queensland have discovered the active compound from an edible mushroom that boosts nerve growth and enhances memory.

Professor Frederic Meunier from the Queensland Brain Institute said the team had identified new active compounds from the mushroom, Hericium erinaceus.

Researchers have discovered lion’s mane mushrooms improve brain cell growth and memory in pre-clinical trials. Image UQ.

U. of I. professor Aron Barbey, pictured, and co-author Evan Anderson found that taking into account the features of the whole brain–rather than focusing on individual regions or networks–allows the most accurate predictions of intelligence.

Patients who received the treatment had less severe brain symptoms and better daily functioning 90 days after the stroke, as compared with those who received clot treatment and a placebo medication.

Butylphthalide is approved and available for use in China, where the study was done. But the medication hasn’t been approved for use by the FDA.

“This is the first trial to show the benefit of using a medication that protects the brain from damage caused by a lack of oxygen to brain tissue. The medication was given to patients with acute ischemic stroke who were also receiving treatment to restore blood flow to the brain,” says co-author Baixue Jia, MD, a doctor of interventional neuroradiology at the Beijing Tiantan Hospital and the China National Clinical Research Center for Neurological Diseases in Beijing.

Summary: Blocking the activity of the reactor called the aryl hydrocarbon receptor in T cells resulted in both a decrease in inflammation and recovery in mouse models of multiple sclerosis.

Source: University of Virginia.

University of Virginia Health neuroscientists have discovered a potential way to disrupt the chronic inflammation responsible for multiple sclerosis.

Immunotherapy is currently a treatment option for breast cancer, melanoma, leukemia, and non-small cell lung cancer.

Researchers are currently looking at using immunotherapy as a treatment for other types of cancer, including prostate cancer, brain cancer, and ovarian cancer.

Do you find yourself buried under an avalanche of tedious coding tasks? Is your brain about to explode from hours of troubleshooting? Fear not, for we have just the solution you need!

In this video we have conjured up 5 magical ways ChatGPT will revolutionize the way you work in data science. Get ready to be spellbound by these 5 enchanting use cases:

Continue reading “ChatGPT for Data Science” »

Neurologists at a memory clinic in China have diagnosed a 19-year-old with what they believe to be Alzheimer’s disease, making him the youngest person to be diagnosed with the condition in the world.

The male teenager began experiencing memory decline around age 17, and the cognitive losses only worsened over the years.

Continue reading “Neurologists Diagnose The Youngest Case of Alzheimer’s Ever Reported” »

Elon Musk’s company Neuralink wants to put a computer chip in everyone’s brain. But the new tech comes with big risk.

Year 2020 face_with_colon_three

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are two fatal and incurable neurodegenerative diseases linked by a shared genetic cause – a heterozygous hexanucleotide (GGGGCC) repeat expansion in a single allele of the C9orf72 gene. The goal of this work is to develop novel CRISPR based therapeutic gene editing technologies and test whether gene editing can reverse the cellular pathology caused by this repeat expansion in patient derived cells. The results of these studies will advance our use of CRISPR technologies for therapeutic editing in FTD/ALS, inform our understanding of the regulation of C9orf72 gene, and will be applicable to many other repeat expansion and single gene disorders.